Publication | Closed Access

Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice

InflammationAnti-inflammatoryMedicineImmunologyPharmacological AgentAnti-inflammatory/antioxidant ActivityPharmacotherapyPharmacologyMapk PathwaysDrug DiscoveryOxidative StressAlleviate Lps